Literature DB >> 28786073

ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway.

Mao-Sheng Fang1, Xing Li2, Hong Qian1, Kuan Zeng1,2, Meng Ye1, Yong-Jie Zhou1, Hui Li1, Xiao-Chuan Wang3,4, Yi Li5.   

Abstract

This study was to determine the protective effect of ω-3 polyunsaturated fatty acids (ω-3PUFAs) on MK-801-induced cognitive impairment in schizophrenia (SZ) rats and the underlying mechanism. A rat model of schizophrenia was induced by MK-801. The cognitive function of rats was assessed using a Morris water maze. The number of hippocampal neurons was measured by Nissl staining. The expression of CREB, p-CREB, BDNF, TrkB, p-TrkB, AKT, p-AKT, ERK, and p-ERK in the hippocampus of rats was detected by Western blotting. The results showed that ω-3PUFAs attenuated MK-801-induced cognitive impairment and hippocampal neurons loss, reversed the injury of the CREB/BDNF/TrkB pathway induced by MK-801, and antagonized MK-801-induced down-regulation of p-AKT and p-ERK in the hippocampus of rats. In conclusion, ω-3PUFAs enhances the CREB/BDNF/TrkB pathway by activating ERK and AKT, thereby increasing the synaptic plasticity and decreasing neuron loss, and antagonizing MK-801-induced cognitive impairment in schizophrenic rats.

Entities:  

Keywords:  CREB/BDNF/TrkB pathway; MK-801; cognition impairment; schizophrenia; ω-3 polyunsaturated fatty acids

Mesh:

Substances:

Year:  2017        PMID: 28786073     DOI: 10.1007/s11596-017-1762-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

1.  Memory impairment in cognitively impaired aged rats associated with decreased hippocampal CREB phosphorylation: reversal by procyanidins extracted from the lotus seedpod.

Authors:  Jiqu Xu; Shuang Rong; Bijun Xie; Zhida Sun; Qianchun Deng; Hailei Wu; Wei Bao; Di Wang; Ping Yao; Fenghong Huang; Liegang Liu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-07       Impact factor: 6.053

Review 2.  BDNF and memory formation and storage.

Authors:  Pedro Bekinschtein; Martin Cammarota; Ivan Izquierdo; Jorge H Medina
Journal:  Neuroscientist       Date:  2007-10-02       Impact factor: 7.519

3.  [Evaluation of correlations between cognitive performances and clinical dimensions of schizophrenia].

Authors:  Ines Johnson; Olfa Ben Azouz; Oussama Kebir; Lamia Dellagi; Isabelle Amado; Karim Tabbane
Journal:  Tunis Med       Date:  2009-10

Review 4.  Diet and cognition: interplay between cell metabolism and neuronal plasticity.

Authors:  Fernando Gomez-Pinilla; Ethika Tyagi
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-11       Impact factor: 4.294

Review 5.  Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.

Authors:  K Iqbal; A D Alonso; J A Gondal; C X Gong; N Haque; S Khatoon; A Sengupta; J Z Wang; I Grundke-Iqbal
Journal:  J Neural Transm Suppl       Date:  2000

Review 6.  The many faces of CREB.

Authors:  William A Carlezon; Ronald S Duman; Eric J Nestler
Journal:  Trends Neurosci       Date:  2005-08       Impact factor: 13.837

Review 7.  Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.

Authors:  Robin Emsley; Piet Oosthuizen; Susan J van Rensburg
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  NMDA receptor antagonist MK-801 reduces neuronal damage and preserves learning and memory in a rat model of traumatic brain injury.

Authors:  Rui-Zhang Han; Jin-Jia Hu; Yuan-Chi Weng; Ding-Feng Li; Yi Huang
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

9.  Cognitive development in schizophrenia: follow-back from the first episode.

Authors:  Robert M Bilder; Gail Reiter; Jay Bates; Todd Lencz; Philip Szeszko; Robert S Goldman; Delbert Robinson; Jeffrey A Lieberman; John M Kane
Journal:  J Clin Exp Neuropsychol       Date:  2006-02       Impact factor: 2.475

10.  Formula feeding potentiates docosahexaenoic and arachidonic acid biosynthesis in term and preterm baboon neonates.

Authors:  Eszter Sarkadi-Nagy; Vasuki Wijendran; Guan Yeu Diau; Angela Chueh Chao; Andrea T Hsieh; Anu Turpeinen; Peter Lawrence; Peter W Nathanielsz; J Thomas Brenna
Journal:  J Lipid Res       Date:  2003-10-01       Impact factor: 5.922

View more
  5 in total

1.  ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia.

Authors:  Cuiping Guo; Yi Liu; Mao-Sheng Fang; Yuanyuan Li; Wensheng Li; Yacoubou Abdoul Razak Mahaman; Kuan Zeng; Yiyuan Xia; Dan Ke; Rong Liu; Jian-Zhi Wang; Hui Shen; Xiji Shu; Xiaochuan Wang
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 7.620

2.  Nogo-A/Pir-B/TrkB Signaling Pathway Activation Inhibits Neuronal Survival and Axonal Regeneration After Experimental Intracerebral Hemorrhage in Rats.

Authors:  Yinlong Liu; Chao Ma; Haiying Li; Haitao Shen; Xiang Li; Xi'an Fu; Jiang Wu; Gang Chen
Journal:  J Mol Neurosci       Date:  2019-07-08       Impact factor: 3.444

3.  Resveratrol, a SIRT1 Activator, Ameliorates MK-801-Induced Cognitive and Motor Impairments in a Neonatal Rat Model of Schizophrenia.

Authors:  Juan Niu; Yuquan Cao; Yongjuan Ji
Journal:  Front Psychiatry       Date:  2020-07-24       Impact factor: 4.157

4.  Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.

Authors:  Bao-Ping Luo; Jing Luo; Yi-Bing Hu; Xiao-Wei Yao; Feng-Hua Wu
Journal:  Curr Med Sci       Date:  2018-06-22

5.  Huang-Pu-Tong-Qiao Formula Ameliorates the Hippocampus Apoptosis in Diabetic Cognitive Dysfunction Mice by Activating CREB/BDNF/TrkB Signaling Pathway.

Authors:  Shu Ye; Dao-Jun Xie; Peng Zhou; Hua-Wu Gao; Meng-Ting Zhang; Da-Bao Chen; Yun-Peng Qin; Xin Lei; Xin-Quan Li; Juan Liu; Ya-Xun Cheng; Yong-Chuan Yao; Biao Cai; Guo-Ming Shen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-09       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.